We are testing a new antibody treatment for patients with solid cancers to see how well it works alone and with other therapies. This study aims to understand its safety and potential benefits.
Health conditions and diseases that the clinical trial is designed to study and treat.
A malignant solid tumor is a type of cancer that forms in solid organs or tissues, often leading to serious health issues. These tumors can be advanced, metastatic, or recurrent, and may express specific markers like mesothelin.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
